Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.83 |
|---|---|
| High | 1.88 |
| Low | 1.58 |
| Bid | 1.58 |
| Offer | 1.69 |
| Previous close | 1.86 |
| Average volume | 810.56k |
|---|---|
| Shares outstanding | 63.72m |
| Free float | 45.41m |
| P/E (TTM) | -- |
| Market cap | 118.52m USD |
| EPS (TTM) | -0.7947 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
- Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
- Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
- Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
- Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
- Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
- Treace Medical Secures Up to $175 Million in Debt Financing
- Treace Announces Participation in Two Upcoming Investor Conferences
- Treace Medical Concepts Reports Third Quarter 2025 Financial Results
- Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
More ▼
